secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001558370-23-010532
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Harmony Biosciences shareholders elect directors, ratify auditors, approve executive compensation at 2023 annual meeting
--------------------------------------------------------------------------------

- Elected Class II directors: Antonio Gracias (41,295,494 for), Jack Bech Nielsen (38,571,010 for), Andreas Wicki (37,229,122 for).
- Ratified Deloitte & Touche as independent auditor for FY2023: 53,633,333 for, 25,629 against, 8,596 abstain.
- Advisory vote approved named executive officer compensation: 51,543,958 for, 1,252,960 against, 406,969 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000155837023010532/0001558370-23-010532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000155837023010532/hrmy-20230525x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-010532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer